JP2024515646A5 - - Google Patents
Info
- Publication number
- JP2024515646A5 JP2024515646A5 JP2023563176A JP2023563176A JP2024515646A5 JP 2024515646 A5 JP2024515646 A5 JP 2024515646A5 JP 2023563176 A JP2023563176 A JP 2023563176A JP 2023563176 A JP2023563176 A JP 2023563176A JP 2024515646 A5 JP2024515646 A5 JP 2024515646A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- cells
- magec2
- peptide
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174808P | 2021-04-14 | 2021-04-14 | |
| US63/174,808 | 2021-04-14 | ||
| US202263329523P | 2022-04-11 | 2022-04-11 | |
| US63/329,523 | 2022-04-11 | ||
| PCT/US2022/024728 WO2022221479A2 (en) | 2021-04-14 | 2022-04-14 | Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515646A JP2024515646A (ja) | 2024-04-10 |
| JP2024515646A5 true JP2024515646A5 (cg-RX-API-DMAC7.html) | 2025-04-21 |
Family
ID=83641016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563176A Pending JP2024515646A (ja) | 2021-04-14 | 2022-04-14 | Magec2免疫原性ペプチド、magec2免疫原性ペプチドを認識する結合性タンパク質、及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240190931A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4323379A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024515646A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240007162A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022256469A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023021162A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216553A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL307601A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012141A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202304964A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022221479A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117820429B (zh) * | 2024-01-11 | 2024-06-18 | 中国水产科学研究院南海水产研究所 | 一种具有inos抑制作用的乌鳢源活性肽 |
| WO2025217028A1 (en) * | 2024-04-08 | 2025-10-16 | Tscan Therapeutics, Inc. | Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof |
| CN120098931B (zh) * | 2025-02-10 | 2026-08-04 | 武建强 | 具有杀伤和肿瘤抑制功效的tcr-t细胞及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5292550B2 (ja) * | 2007-03-23 | 2013-09-18 | 静岡県 | T細胞レセプターβ鎖遺伝子及びα鎖遺伝子 |
| ES2635335T3 (es) * | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| US9205144B2 (en) * | 2011-06-03 | 2015-12-08 | Dana-Farber Cancer Institute, Inc. | Identification of conserved peptide blocks in homologous polypeptides |
| GB201520539D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| WO2019075385A1 (en) * | 2017-10-12 | 2019-04-18 | Board Of Regents, The University Of Texas System | T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY |
| CN109776671B (zh) * | 2017-11-14 | 2022-05-27 | 杭州康万达医药科技有限公司 | 分离的t细胞受体、其修饰的细胞、编码核酸、表达载体、制备方法、药物组合物和应用 |
| AU2018395397A1 (en) * | 2017-12-28 | 2020-08-06 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| BR112020016330A8 (pt) * | 2018-02-12 | 2023-04-18 | Hutchinson Fred Cancer Res | Receptores de células t específicas a ciclina a1 e usos dos mesmos |
| TW202000907A (zh) * | 2018-05-23 | 2020-01-01 | 美商葛利史東腫瘤科技公司 | 共有抗原 |
| AU2019321608B2 (en) * | 2018-08-16 | 2024-07-25 | Biontech Us Inc. | T cell receptor constructs and uses thereof |
| GB201814362D0 (en) * | 2018-09-04 | 2018-10-17 | Treos Bio Zrt | Composition and process for preparing vaccine |
| CN112912391B (zh) * | 2018-10-25 | 2026-07-03 | 昆士兰医学研究所理事会 | T细胞受体及其用途 |
| CA3126707A1 (en) * | 2019-01-29 | 2020-08-06 | Gritstone Bio, Inc. | Multispecific binding proteins |
-
2022
- 2022-04-14 KR KR1020237038886A patent/KR20240007162A/ko active Pending
- 2022-04-14 JP JP2023563176A patent/JP2024515646A/ja active Pending
- 2022-04-14 AU AU2022256469A patent/AU2022256469A1/en active Pending
- 2022-04-14 CA CA3216553A patent/CA3216553A1/en active Pending
- 2022-04-14 WO PCT/US2022/024728 patent/WO2022221479A2/en not_active Ceased
- 2022-04-14 BR BR112023021162A patent/BR112023021162A2/pt unknown
- 2022-04-14 US US18/286,728 patent/US20240190931A1/en active Pending
- 2022-04-14 TW TW111114234A patent/TW202304964A/zh unknown
- 2022-04-14 MX MX2023012141A patent/MX2023012141A/es unknown
- 2022-04-14 EP EP22788903.7A patent/EP4323379A4/en active Pending
- 2022-04-14 IL IL307601A patent/IL307601A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110785432B (zh) | Tcr和肽 | |
| TWI735765B (zh) | T細胞受體及其針對prame陽性癌症的免疫治療 | |
| JP7770188B2 (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| JP2024546018A5 (cg-RX-API-DMAC7.html) | ||
| TWI908730B (zh) | 識別p53中之r175h或y220c突變之t細胞受體 | |
| JP5729887B2 (ja) | T細胞レセプターβ鎖遺伝子及びα鎖遺伝子 | |
| JP2023534808A (ja) | 養子細胞療法のための標的共刺激を提供する受容体 | |
| JP2020529830A (ja) | 新規t細胞受容体およびそれを用いた免疫療法 | |
| JP2024517618A5 (cg-RX-API-DMAC7.html) | ||
| CN114502580B (zh) | Mhc ii类分子及其使用方法 | |
| CN113195526B (zh) | 针对过继性t细胞疗法中的突变myd88l265p蛋白表位的特异性t细胞受体 | |
| JP2023549765A5 (cg-RX-API-DMAC7.html) | ||
| EP3898665B1 (en) | Cd22-specific t cell receptors and adoptive t cell therapy for treatment of b cell malignancies | |
| JP2022546106A (ja) | Ebv-由来抗原に特異的なtcr構築物 | |
| Nakatsugawa et al. | CD4+ and CD8+ TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells | |
| CN114450303B (zh) | Mhc ii类分子及其使用方法 | |
| EP4091627A1 (en) | Tcr constructs specific for magea4-derived epitopes | |
| US20190359677A1 (en) | Novel t cell receptors and immune therapy using the same for the treatment of cancer and infectious diseases | |
| TWI790162B (zh) | 新穎t細胞受器及使用其之免疫治療 | |
| TW202406569A (zh) | 多重t細胞受體組合物、組合療法及其用途 | |
| JP2025518203A (ja) | Mage-a1特異的tcr及びその用途 | |
| JP2025516264A5 (cg-RX-API-DMAC7.html) | ||
| EP4491630A1 (en) | T-cell receptor for acute myeloid leukemia (aml) | |
| US12209137B2 (en) | Antigen binding proteins specifically binding CT45 | |
| EP4223782A1 (en) | Novel t cell receptors and immune therapy using the same for the treatment of cancer |